The impact of stress hyperglycemia and its molecular pathogenesis on cardiac dysfunction, the optimal glucose targets as well as the insulin doses and timing to be recommended during states of acute heart failure and myocardial infarction are some of the topics and controversies that stimulate our curiosity. This evidence concerns the gene INS and myocardial infarction.